Literature DB >> 27300527

Applications of Molecular Genetics to the Study of Asthma.

Catalina S Sanz-Lozano1,2, Virginia García-Solaesa3,4, Ignacio Davila3,5,6, María Isidoro-García3,7,8.   

Abstract

Asthma is a multifactorial disease. This fact, associated to the diversity of asthma phenotypes, has made difficult to obtain a clear pattern of inheritance. With the huge development of molecular genetics technologies, candidate gene studies are giving way to different types of studies from the genomic point of view.These approaches are allowing the identification of several genes associated with asthma. However, in these studies, there are some conflicting results between different populations and there is still a lack of knowledge about the actual influence of the gene variants. Some confounding factors are, among others, the inappropriate sample size, population stratification, differences in the classification of the phenotypes, or inadequate coverage of the genes.To confirm the real effect of the reported associations, it is necessary to consider both the genetic and environmental factors and perform functional studies that explain the molecular mechanisms mediating between the emergence of gene variants and the development of the disease.The development of experimental techniques opens a new horizon that allows the identification of major genetic factors of susceptibility to asthma. The resulting classification of the population groups based on their genetic characteristics, will allow the application of specific and highly efficient treatments.

Entities:  

Keywords:  Asthma; Candidate genes; GWAS; Next-generation sequencing; Phenotype

Mesh:

Year:  2016        PMID: 27300527     DOI: 10.1007/978-1-4939-3652-6_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

Review 1.  The recurrence risk of genetic complex diseases.

Authors:  Mahdi Bijanzadeh
Journal:  J Res Med Sci       Date:  2017-03-15       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.